# 11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced Neuroinflammation

> **NCT02811744** · PHASE2 · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 11 (actual)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

- **DRUG:** 11C-acetate

## Key facts

- **NCT ID:** NCT02811744
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-02-28
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Funding issues.
- **Last updated:** 2024-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02811744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02811744, "11C-Acetate PET/CT Imaging As a Biomarker of Amyloid-Induced Neuroinflammation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02811744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*